Search research articles
Contact Us
Filters
Showing results (21-30 of 263) with videos related to
Page
of 27
Sort By:
Progress in Clinical and Biological Research
|
January 1, 1986
Slow hydroxylation of tricyclic antidepressants--relationship to polymorphic drug oxidation
F Sjöqvist, L Bertilsson
Clinical Pharmacology and Therapeutics
|
May 1, 1993
Why are diazepam metabolism and polymorphic S-mephenytoin hydroxylation associated with each other in white and Korean populations but not in Chinese populations?
L Bertilsson, W Kalow
Lancet (London, England)
|
November 2, 1985
Side-effects of carbamazepine: drug or metabolite?
T Tomson, L Bertilsson
Epilepsy Research. Supplement
|
January 1, 1991
Kinetics, metabolism and effects of carbamazepine-10,11-epoxide in man
T Tomson, L Bertilsson
Clinical Pharmacokinetics
|
January 1, 1995
Active hydroxymetabolites of antidepressants. Emphasis on E-10-hydroxy-nortriptyline
C Nordin, L Bertilsson
Therapeutic Drug Monitoring
|
May 1, 1990
d-Propoxyphene is a potent inhibitor of debrisoquine, but not S-mephenytoin 4-hydroxylation in vivo
E J Sanz, L Bertilsson
Pharmacogenetics
|
April 26, 2000
Rapid high-performance liquid chromatographic method for determination of debrisoquine and 4-hydroxy-debrisoquine in urine for CYP2D6 phenotyping
J O Svensson, L Bertilsson
British Journal of Clinical Pharmacology
|
March 1, 1983
The debrisoquine hydroxylation test predicts steady-state plasma levels of desipramine
L Bertilsson, A Aberg-Wistedt
Biochemistry
|
July 6, 1971
Methylation of mercury compounds by methylcobalamin
L Bertilsson, H Y Neujahr
Brain Research
|
December 12, 1975
Comparison of the effects of lesion in the 'B9' cell body group and p-chloroamphetamine on tryptophan hydroxylase and 5-hydroxytryptamine in rat brain nuclei
J L Meek, L Bertilsson
Page
of 27
Search research articles
Search
Showing results (21-30 of 263) with videos related to
Sort By:
Page
of 27
Progress in Clinical and Biological Research
|
January 1, 1986
Slow hydroxylation of tricyclic antidepressants--relationship to polymorphic drug oxidation
F Sjöqvist, L Bertilsson
Clinical Pharmacology and Therapeutics
|
May 1, 1993
Why are diazepam metabolism and polymorphic S-mephenytoin hydroxylation associated with each other in white and Korean populations but not in Chinese populations?
L Bertilsson, W Kalow
Lancet (London, England)
|
November 2, 1985
Side-effects of carbamazepine: drug or metabolite?
T Tomson, L Bertilsson
Epilepsy Research. Supplement
|
January 1, 1991
Kinetics, metabolism and effects of carbamazepine-10,11-epoxide in man
T Tomson, L Bertilsson
Clinical Pharmacokinetics
|
January 1, 1995
Active hydroxymetabolites of antidepressants. Emphasis on E-10-hydroxy-nortriptyline
C Nordin, L Bertilsson
Therapeutic Drug Monitoring
|
May 1, 1990
d-Propoxyphene is a potent inhibitor of debrisoquine, but not S-mephenytoin 4-hydroxylation in vivo
E J Sanz, L Bertilsson
Pharmacogenetics
|
April 26, 2000
Rapid high-performance liquid chromatographic method for determination of debrisoquine and 4-hydroxy-debrisoquine in urine for CYP2D6 phenotyping
J O Svensson, L Bertilsson
British Journal of Clinical Pharmacology
|
March 1, 1983
The debrisoquine hydroxylation test predicts steady-state plasma levels of desipramine
L Bertilsson, A Aberg-Wistedt
Biochemistry
|
July 6, 1971
Methylation of mercury compounds by methylcobalamin
L Bertilsson, H Y Neujahr
Brain Research
|
December 12, 1975
Comparison of the effects of lesion in the 'B9' cell body group and p-chloroamphetamine on tryptophan hydroxylase and 5-hydroxytryptamine in rat brain nuclei
J L Meek, L Bertilsson
Page
of 27